115 related articles for article (PubMed ID: 12632485)
21. [Expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma].
Hao Y; Jin C; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):457-61. PubMed ID: 23898609
[TBL] [Abstract][Full Text] [Related]
22. [Expression of Ras-GTPase-activating protein SH 3 domain binding protein and osteopontin in esophageal squamous carcinoma and their effects on prognosis].
Liu JG; Zhang HZ; Wei YP; Wu C; Cao YK; Wang M
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):73-6. PubMed ID: 17253181
[TBL] [Abstract][Full Text] [Related]
23. p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus.
Chen G; Burger MM
Int J Cancer; 1999 Apr; 84(2):95-100. PubMed ID: 10096238
[TBL] [Abstract][Full Text] [Related]
24. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract][Full Text] [Related]
26. [Dysregulation of Annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province].
Qi YJ; Wang LD; Jiao XY; Feng XS; Fan ZM; Gao SS; He X; Li JL; Chang FB
Ai Zheng; 2007 Jul; 26(7):730-6. PubMed ID: 17626749
[TBL] [Abstract][Full Text] [Related]
27. [Expression of activin A in tissue and serum of patients with esophageal squamous cell carcinoma and its clinical significance].
Liu SG; Li HC; Zhao BS; Cao F
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):843-7. PubMed ID: 24447483
[TBL] [Abstract][Full Text] [Related]
28. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
He F; Li H; Li WS; Dong XH
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
[TBL] [Abstract][Full Text] [Related]
29. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
30. [Expression of mir-106b in esophageal squamous cell carcinoma].
Xiao CY; Guo ZJ; Cao L; Ding XW; Liu Q; Wang XC
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1667-1671. PubMed ID: 27998862
[TBL] [Abstract][Full Text] [Related]
31. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.
Ku JW; Zhang DY; Song X; Li XM; Zhao XK; Lv S; Hu SJ; Cheng R; Zhou FY; Wu HF; Wang LD
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575250
[TBL] [Abstract][Full Text] [Related]
32. NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma.
Chen GQ; Tian H; Yue WM; Li L; Li SH; Qi L; Gao C; Si LB; Lu M
Med Oncol; 2014 Dec; 31(12):376. PubMed ID: 25416054
[TBL] [Abstract][Full Text] [Related]
33. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang HR; Wang MH; Lian GY; Wu DG
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):99-102. PubMed ID: 25613619
[TBL] [Abstract][Full Text] [Related]
34. Expression of Cofilin-1 and Transgelin in Esophageal Squamous Cell Carcinoma.
Zhang Y; Liao R; Li H; Liu L; Chen X; Chen H
Med Sci Monit; 2015 Sep; 21():2659-65. PubMed ID: 26344167
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
36. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Toyozumi T; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Okada K; Shiraishi T; Komatsu A; Iida K; Matsubara H
Oncology; 2018; 94(3):142-148. PubMed ID: 29216641
[TBL] [Abstract][Full Text] [Related]
37. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang H; Wang M; Lian G; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):99-102. PubMed ID: 23353165
[TBL] [Abstract][Full Text] [Related]
38. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
39. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
40. Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma.
Liu J; Hu Y; Xie X; Fu J
Ann Thorac Surg; 2012 Feb; 93(2):423-7. PubMed ID: 22178587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
